- €866.26m
- €724.42m
- €529.27m
- 89
- 40
- 69
- 77
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.14 | ||
| PEG Ratio (f) | 2.46 | ||
| EPS Growth (f) | 6.11% | ||
| Dividend Yield (f) | 1.21% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.6 | ||
| Price to Tang. Book | 2.71 | ||
| Price to Free Cashflow | 12.33 | ||
| Price to Sales | 1.61 | ||
| EV to EBITDA | 7.91 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.61% | ||
| Return on Equity | 8.99% | ||
| Operating Margin | 12.27% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 395.99 | 427.47 | 521.27 | 539.78 | 529.27 | 537.98 | 555.13 | 7.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -11.37 | -8.86 | +116.48 | -13.77 | +6.08 | -0.62 | +6.11 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vetoquinol SA is a France-based company that specializes in the research, development, manufacture, marketing and sale of veterinary drugs and products. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The Company markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. It trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
Directors
- Etienne Frechin CHM (84)
- Matthieu Frechin CEO (53)
- Alain Masson DCE (60)
- Dominique Derveaux COO
- Jean-charles Frechin DRC (77)
- Martine Frechin DRC (83)
- Philippe Arnold IND (81)
- Marie-Josephe Baud IND (73)
- Louis Champel IND (78)
- Elisabeth Pacaud IND (66)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1962
- Public Since
- November 16th, 2006
- No. of Employees
- 2,519
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Euronext - Paris- Shares in Issue
- 11,834,162
- Address
- Sainte-Anne 34 rue du Chene, LURE, 70204
- Web
- https://www.vetoquinol.com/fr
- Phone
- +33 384625555
- Auditors
- MAZARS
Upcoming Events for VETO
Vetoquinol SA Annual Shareholders Meeting
Dividend For VETO.PA - 0.8900 EUR
Half Year 2025 Vetoquinol SA Earnings Call
Half Year 2025 Vetoquinol SA Earnings Release
Similar to VETO
AB Science SA
Euronext - Paris
Advicenne SA
Euronext - Paris
Aelis Farma SA
Euronext - Paris
Boiron SA
Euronext - Paris
DBV Technologies SA
Euronext - Paris
FAQ
What is the Vetoquinol SA share price?
As of Today at 23:58 UTC, shares in Vetoquinol SA are trading at €73.20. This share price information is delayed by 15 minutes.
How has the Vetoquinol SA share price performed this year?
Shares in Vetoquinol SA last closed at €73.20 and the price had moved by -25.31% over the past 365 days. In terms of relative price strength the Vetoquinol SA share price has underperformed the FTSE Global All Cap Index by -27.18% over the past year.
What are the analyst and broker recommendations for Vetoquinol SA?
The overall consensus recommendation for Vetoquinol SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Vetoquinol SA dividend yield?
The Vetoquinol SA dividend yield is 1.16% based on the trailing twelve month period.
Does Vetoquinol SA pay a dividend?
Last year, Vetoquinol SA paid a total dividend of €0.85, and it currently has a trailing dividend yield of 1.16%.Looking ahead, shares in Vetoquinol SA are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-06-06.
When does Vetoquinol SA next pay dividends?
Vetoquinol SA are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-06-06. The historic dividend yield on Vetoquinol SA shares is currently 1.16%.
How do I buy Vetoquinol SA shares?
To buy shares in Vetoquinol SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vetoquinol SA?
As of the previous close price of €73.20, shares in Vetoquinol SA had a market capitalisation of €866.26m.
Where are Vetoquinol SA shares listed?
Here are the trading details for Vetoquinol SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: VETO
What kind of share is Vetoquinol SA?
Based on an overall assessment of its quality, value and momentum Vetoquinol SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vetoquinol SA share price forecast for 2025?
The analyst consensus target price for shares in Vetoquinol SA is €94.20. That is 28.69% above the last closing price of €73.20.
Analysts covering Vetoquinol SA currently have a consensus Earnings Per Share (EPS) forecast of €4.88 for the next financial year.
Find out moreWhat is the trend in the Vetoquinol SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vetoquinol SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.52%.
As of the last closing price of €73.20, shares in Vetoquinol SA were trading -10.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vetoquinol SA PE Ratio?
The Vetoquinol SA PE ratio based on its reported earnings over the past 12 months is 14.14. The shares last closed at €73.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vetoquinol SA?
Vetoquinol SA's management team is headed by:
- Etienne Frechin - CHM
- Matthieu Frechin - CEO
- Alain Masson - DCE
- Dominique Derveaux - COO
- Jean-charles Frechin - DRC
- Martine Frechin - DRC
- Philippe Arnold - IND
- Marie-Josephe Baud - IND
- Louis Champel - IND
- Elisabeth Pacaud - IND